4.6 Article

The Transcriptional Regulator Id2 Is Critical for Adipose-Resident Regulatory T Cell Differentiation, Survival, and Function

Journal

JOURNAL OF IMMUNOLOGY
Volume 203, Issue 3, Pages 658-664

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1900358

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01 DK114012, R01 DK119627]
  2. University of Pittsburgh

Ask authors/readers for more resources

Adipose regulatory T cells (aTregs) have emerged as critical cells for the control of local and systemic inflammation. In this study, we show a distinctive role for the transcriptional regulator Id2 in the differentiation, survival, and function of aTregs in mice. Id2 was highly expressed in aTregs compared with high Id3 expression in lymphoid regulatory T cells (Tregs). Treg-specific deletion of Id2 resulted in a substantial decrease in aTregs, whereas Tregs in the spleen and lymph nodes were unaffected. Additionally, loss of Id2 resulted in decreased expression of aTreg-associated markers, including ST2, CCR2, KLRG1, and GATA3. Gene expression analysis revealed that Id2 expression was essential for the survival of aTregs, and loss of Id2 increased cell death in aTregs due to increased Fas expression. Id2-mediated aTreg depletion resulted in increased systemic inflammation, increased inflammatory macrophages and CD8(+) effector T cells, and loss of glucose tolerance under standard diet conditions. Thus, we reveal an unexpected and novel function for Id2 in mediating differentiation, survival, and function of aTregs that when lost result in increased metabolic perturbation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Invariant natural killer T-cell development and function with loss of microRNA-155

Adolfo B. Frias, Heather M. Buechel, Arpan Neupane, Louise M. D'Cruz

IMMUNOLOGY (2018)

Article Immunology

The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8+ Memory T Cell Maintenance and Secondary Response to Infection

Ann R. Piccirillo, Eric J. Hyzny, Lisa Y. Beppu, Ashley V. Menk, Callen T. Wallace, William F. Hawse, Heather M. Buechel, Bernice H. Wong, Juat Chin Foo, Amaury Cazenave-Gassiot, Markus R. Wenk, Greg M. Delgoffe, Simon C. Watkins, David L. Silver, Louise M. D'Cruz

JOURNAL OF IMMUNOLOGY (2019)

Review Immunology

Epigenetic regulation of T cell adaptive immunity

Adolfo B. Frias, Shannon K. Boi, Xin Lan, Ben Youngblood

Summary: The concept of adaptive immunity, based on immunological memory, has paved the way for modern vaccination and immunotherapy. Recent studies have identified epigenetic programs as a molecular mechanism governing T cell subset specification and immunological memory.

IMMUNOLOGICAL REVIEWS (2021)

Review Surgery

A review of liver dysfunction in the lung transplant patient

Eric J. Hyzny, Ernest G. Chan, Matthew Morrell, Takashi Harano, Pablo G. Sanchez

Summary: Liver dysfunction is increasingly common in patients evaluated for lung transplantation, and new or worsening dysfunction is associated with high short- and long-term mortality rates. Thorough liver function assessment is necessary prior to listing for lung transplant. Combined lung and liver transplantation may provide a long-term management option for high-risk patients, but indications and experience with the combined operation remain unclear.

CLINICAL TRANSPLANTATION (2021)

Article Cardiac & Cardiovascular Systems

Intraoperative Support for Primary Bilateral Lung Transplantation: A Propensity-Matched Analysis

Ernest G. Chan, Eric J. Hyzny, Masashi Furukawa, John P. Ryan, Kathirvel Subramaniam, Matthew R. Morrell, Joseph Pilewski, James D. Luketich, Pablo G. Sanchez

Summary: This study compared the outcomes of intraoperative venoarterial extracorporeal membrane oxygenation (VA-ECMO) and cardiopulmonary bypass (CPB) during lung transplantation. The results showed that compared to the CPB group, the VA-ECMO group required fewer blood transfusions, had a shorter duration of mechanical ventilation, and had a lower incidence of grade 3 primary graft dysfunction at 72 hours. However, there were no differences in survival between the two groups.

ANNALS OF THORACIC SURGERY (2023)

Article Cardiac & Cardiovascular Systems

Risk Factors and Outcomes of Postoperative Hepatic Dysfunction After Lung Transplantation

Eric J. Hyzny, Ernest G. Chan, Shahid M. Malik, Matthew Morrell, Masashi Furukawa, John P. Ryan, Pablo G. Sanchez

Summary: This retrospective analysis of 1406 adult lung transplant recipients found that postoperative hepatic dysfunction is associated with significant morbidity and mortality. A history of liver disease was the best predictor for postoperative dysfunction. Further research is needed to identify better treatment strategies to prevent hepatic dysfunction after lung transplantation.

ANNALS OF THORACIC SURGERY (2023)

Article Surgery

A novel scoring system to predict survival in cirrhotic patients undergoing isolated lung transplantation: The PENS-CEPT score

Eric J. Hyzny, Ernest G. Chan, Chadi Hage, Vikrant Rachakonda, Pablo G. Sanchez, Shahid M. Malik

Summary: A scoring system (PENS-CEPT) combining clinical data and preoperative imaging was developed to determine the safety of isolated lung transplantation (ILT) in cirrhotic patients. The score predicted 1-year survival and could effectively identify high-risk patients who are not suitable for ILT. This study highlights the potential of the scoring system in increasing the opportunity for cirrhotic patients to undergo ILT.

CLINICAL TRANSPLANTATION (2023)

No Data Available